Northwest Biotherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $31.3M
Liabilities Breakdown FY2022
Total Liabilities: $136.4M
Asset Breakdown
Total Assets: $31.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.0M | 22.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.4M | 42.8% |
| Goodwill | $626.0K | 2.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $10.3M | 32.9% |
Liabilities Breakdown
Total Liabilities: $136.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $21.5M | 15.8% |
| Other Liabilities | $114.8M | 84.2% |